|
|
 |
|
Viewing report
|
|
|
|
Analgesics in Spain
Euromonitor International, Dec 2007, Pages: 31
Our Analgesics in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.
Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics
Data coverage: market sizes (historic and forecasts), company shares, brand shares
Why buy this report?
- Get a detailed picture of the analgesics industry
- Pinpoint growth sectors and trends and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop
EXECUTIVE SUMMARY
Demographics Shaping Sales
Two main demographic factors are crucial in explaining the development of OTC sales in Spain in the latter part of the review period. The first is the birth rate, which recovered in 2005 and 2006, and with it growth in childspecific products. The second is the ageing of the Spanish population, which is contributing positively to sales of medicated skin care and digestive remedies.
Low Incidence of Flu Shapes Sales for the Second Year in A Row
Much in line with 2005, value sales of OTC products were limited by the low influence of the flu in 2006. This, along with the mild temperatures registered in the winter of 2006, limited sales of cough and cold remedies and analgesics, and had a significant impact on the wider Spanish OTC market.
Fragmentation Defines Spanish OTC Market
With over 100 companies active in OTC healthcare in Spain, fragmentation largely characterises the market, as a result of a high degree of specialisation within sectors. According to industry sources, most pharmaceutical companies specialise in one or two subsectors, which leads to a substantial number of players being in the market.
Internet Arrived
Although in 2006, some 90% of OTC value sales were still made through pharmacies, Internet selling has arrived, with new legislation regarding the distribution of medicines. Whilst the law forbids the selling of prescription medicines via the Internet or other distant-selling mechanisms, the sale of non-reimbursed nonprescription medicines is permitted.
New Legal Framework
In June 2006, the Ministry of Health passed new legislation regarding medicines, which will come into force in 2007. This new legislation changes the legal framework for OTC healthcare in Spain, although non-reimbursed non-prescription medicines are not greatly affected.
Other new laws are expected to be passed in the near future. New legislation regulating food supplements, antialcoholism legislation and further legislation to enhance public health are set to benefit the performance of OTC products over the forecast period.
Customers who bought this item also bought
Analgesics in Poland
Analgesics in Russia
Johnson & Johnson Inc: OTC Healthcare
Analgesics in Germany
Analgesics in China
Analgesics in Ireland
Analgesics in Canada
Beiersdorf AG: OTC Healthcare
The World Market for OTC Healthcare
OTC Healthcare in Kazakhstan
OTC Analgesics in the United States
OTC Healthcare in Georgia
|
|
|
|
